414 related articles for article (PubMed ID: 18334878)
1. Prevalence of gastrointestinal symptoms in patients with chronic obstructive pulmonary disease.
Niklasson A; Strid H; Simrén M; Engström CP; Björnsson E
Eur J Gastroenterol Hepatol; 2008 Apr; 20(4):335-41. PubMed ID: 18334878
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of gastroesophageal reflux disease in patients with asthma and chronic obstructive pulmonary disease.
Bor S; Kitapcioglu G; Solak ZA; Ertilav M; Erdinc M
J Gastroenterol Hepatol; 2010 Feb; 25(2):309-13. PubMed ID: 19817951
[TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal-specific anxiety: an important factor for severity of GI symptoms and quality of life in IBS.
Jerndal P; Ringström G; Agerforz P; Karpefors M; Akkermans LM; Bayati A; Simrén M
Neurogastroenterol Motil; 2010 Jun; 22(6):646-e179. PubMed ID: 20367800
[TBL] [Abstract][Full Text] [Related]
4. Fatigue in patients with primary sclerosing cholangitis.
Björnsson E; Simren M; Olsson R; Chapman RW
Scand J Gastroenterol; 2004 Oct; 39(10):961-8. PubMed ID: 15513335
[TBL] [Abstract][Full Text] [Related]
5. No difference in symptoms of irritable bowel syndrome between healthy subjects and patients with recurrent depression in remission.
Karling P; Danielsson A; Adolfsson R; Norrback KF
Neurogastroenterol Motil; 2007 Nov; 19(11):896-904. PubMed ID: 17973640
[TBL] [Abstract][Full Text] [Related]
6. Internet-based assessment of bowel symptoms and quality of life.
Enck P; Kowalski A; Martens U; Klosterhalfen S
Eur J Gastroenterol Hepatol; 2006 Dec; 18(12):1263-9. PubMed ID: 17099374
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of treatment for gastro-oesophageal reflux disease with a proton pump inhibitor, and relationship between gastro-oesophageal reflux disease and Helicobacter pylori infection in Japan.
Muramatsu A; Azuma T; Okajima T; Ohtani M; Dojo M; Yamazaki Y; Kuriyama M
Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():102-6. PubMed ID: 15298614
[TBL] [Abstract][Full Text] [Related]
8. Overlap of gastro-oesophageal reflux disease and irritable bowel syndrome: prevalence and risk factors in the general population.
Jung HK; Halder S; McNally M; Locke GR; Schleck CD; Zinsmeister AR; Talley NJ
Aliment Pharmacol Ther; 2007 Aug; 26(3):453-61. PubMed ID: 17635380
[TBL] [Abstract][Full Text] [Related]
9. Quality of life in short-bowel syndrome: impact of fatigue and gastrointestinal symptoms.
Kalaitzakis E; Carlsson E; Josefsson A; Bosaeus I
Scand J Gastroenterol; 2008; 43(9):1057-65. PubMed ID: 18609190
[TBL] [Abstract][Full Text] [Related]
10. Concomitant functional dyspepsia and irritable bowel syndrome decrease health-related quality of life in gastroesophageal reflux disease.
De Vries DR; Van Herwaarden MA; Baron A; Smout AJ; Samsom M
Scand J Gastroenterol; 2007 Aug; 42(8):951-6. PubMed ID: 17613924
[TBL] [Abstract][Full Text] [Related]
11. The use of the Hospital Anxiety and Depression Scale (HADS) in patients with chronic obstructive pulmonary disease: a pilot study.
Dowson C; Laing R; Barraclough R; Town I; Mulder R; Norris K; Drennan C
N Z Med J; 2001 Oct; 114(1141):447-9. PubMed ID: 11700772
[TBL] [Abstract][Full Text] [Related]
12. Impact of dialysis on gastroesophageal reflux, dyspepsia, and proton pump inhibitor treatment in patients with chronic renal failure.
Strid H; Fjell A; Simrén M; Björnsson ES
Eur J Gastroenterol Hepatol; 2009 Feb; 21(2):137-42. PubMed ID: 19212202
[TBL] [Abstract][Full Text] [Related]
13. High prevalence of irritable bowel syndrome and upper gastrointestinal symptoms in patients with chronic renal failure.
Kahvecioglu S; Akdag I; Kiyici M; Gullulu M; Yavuz M; Ersoy A; Dilek K; Yurtkuran M
J Nephrol; 2005; 18(1):61-6. PubMed ID: 15772924
[TBL] [Abstract][Full Text] [Related]
14. Reflux and irritable bowel syndrome are negative predictors of quality of life in coeliac disease and inflammatory bowel disease.
Barratt SM; Leeds JS; Robinson K; Shah PJ; Lobo AJ; McAlindon ME; Sanders DS
Eur J Gastroenterol Hepatol; 2011 Feb; 23(2):159-65. PubMed ID: 21178777
[TBL] [Abstract][Full Text] [Related]
15. The prevalence and pattern of gastroesophageal reflux symptoms in perimenopausal and menopausal women.
Infantino M
J Am Acad Nurse Pract; 2008 May; 20(5):266-72. PubMed ID: 18460167
[TBL] [Abstract][Full Text] [Related]
16. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life.
Ng TP; Niti M; Tan WC; Cao Z; Ong KC; Eng P
Arch Intern Med; 2007 Jan; 167(1):60-7. PubMed ID: 17210879
[TBL] [Abstract][Full Text] [Related]
17. Hypervigilance in irritable bowel syndrome compared with organic gastrointestinal disease.
Posserud I; Svedlund J; Wallin J; Simrén M
J Psychosom Res; 2009 May; 66(5):399-405. PubMed ID: 19379956
[TBL] [Abstract][Full Text] [Related]
18. Subjective theories of illness and clinical and psychological outcomes in patients with irritable bowel syndrome.
Riedl A; Maass J; Fliege H; Stengel A; Schmidtmann M; Klapp BF; Mönnikes H
J Psychosom Res; 2009 Nov; 67(5):449-55. PubMed ID: 19837208
[TBL] [Abstract][Full Text] [Related]
19. Psychological comorbidity and complexity of gastrointestinal symptoms in clinically diagnosed irritable bowel syndrome patients.
Mikocka-Walus A; Turnbull D; Moulding N; Wilson I; Andrews JM; Holtmann G
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1137-43. PubMed ID: 18070012
[TBL] [Abstract][Full Text] [Related]
20. Gastroesophageal reflux symptoms and well-being in a random sample of the general population of a Swedish community.
Wiklund I; Carlsson J; Vakil N
Am J Gastroenterol; 2006 Jan; 101(1):18-28. PubMed ID: 16405529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
